Cargando…

Treatment or Prophylaxis against Hepatitis B Virus Infection in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: An Update

Chronic hepatitis B virus (HBV) flares or reactivations are serious causes of morbidity or mortality in rheumatologic patients undergoing immunosuppressive therapy. The recent insights in the pathogenesis of rheumatic diseases led to the use of new immunosuppressive therapies indicated in case of fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stasi, Cristina, Tiengo, Giacomo, Sadalla, Sinan, Zignego, Anna Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227638/ https://www.ncbi.nlm.nih.gov/pubmed/34200522 http://dx.doi.org/10.3390/jcm10122564

Ejemplares similares

Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
por: Stasi, Cristina, et al.
Publicado: (2014)

Hepatitis B vaccination and immunotherapies: an update
por: Stasi, Cristina, et al.
Publicado: (2020)

Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis
por: Clemente Garulo, Daniel, et al.
Publicado: (2023)

Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection
por: Anna, Linda Zignego, et al.
Publicado: (2018)

Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
por: Elsebaey, Mohamed A., et al.
Publicado: (2022)

Improvement of Rheumatic Valvular Heart Disease in Patients Undergoing Prolonged Antibiotic Prophylaxis
por: Torres, Renato Pedro de Almeida, et al.
Publicado: (2021)

Emerging Trends in Epidemiology of Hepatitis B Virus Infection
por: Stasi, Cristina, et al.
Publicado: (2017)

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012)

Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis
por: Frazzoni, Leonardo, et al.
Publicado: (2021)

Treatment of rheumatic diseases and hepatitis B virus coinfection
por: Felis-Giemza, Anna, et al.
Publicado: (2014)

Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination
por: Stasi, Cristina, et al.
Publicado: (2020)

Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?
por: Harmancı, Özgür, et al.
Publicado: (2014)

Vertical Transmission of Hepatitis B Virus—An Update
por: di Filippo Villa, Diana, et al.
Publicado: (2023)

Secondary prophylaxis in rheumatic fever: is it time to change?
por: Taddio, Andrea, et al.
Publicado: (2015)

Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening)
por: Cuadros, Esmeralda Núñez, et al.
Publicado: (2022)

Poster 103: Incidence of postoperative infections in rheumatic disease patients undergoing arthroscopy was not affected by use of immunosuppressive medications
por: Jazrawi, Laith, et al.
Publicado: (2022)

Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy
por: Ooka, Kohtaro, et al.
Publicado: (2016)

Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact
por: Zignego, Anna Linda, et al.
Publicado: (2012)

COVID-19 in rheumatic disease patients on immunosuppressive agents
por: Sharmeen, Saika, et al.
Publicado: (2020)

Adherence to Secondary Prophylaxis Among Patients with Acute  Rheumatic Fever and Rheumatic Heart Disease
por: Woods, John A., et al.
Publicado: (2019)

Correction to: Position statement of the Spanish society of pediatric rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: part 1 (screening)
por: Núñez Cuadros, Esmeralda, et al.
Publicado: (2022)

Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia
por: Fognani, Elisa, et al.
Publicado: (2013)

Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis
por: Nelson, Noele P.
Publicado: (2017)

Protective Role of Rheumatic Diseases Against Hepatitis B Virus Infection and Human Leukocyte Antigen B27 Highlighted
por: Ye, Junna, et al.
Publicado: (2022)

Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab
por: Ajeganova, Sofia, et al.
Publicado: (2017)

Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
por: Kevat, Priya M., et al.
Publicado: (2017)

Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study
por: Sugihara, Koichi, et al.
Publicado: (2022)

Is it safe to vaccinate rheumatic immunosuppressed patients? Yes, of course, but how?
por: Gillet, Pierre
Publicado: (2021)

A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy
por: Chen, Wen-Chi, et al.
Publicado: (2015)

Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
por: Koutsianas, Christos, et al.
Publicado: (2020)

Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
por: Chamberlain-Salaun, Jennifer, et al.
Publicado: (2016)

COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination
por: Gentile, Ivan, et al.
Publicado: (2022)

An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt
por: Balbaa, A, et al.
Publicado: (2015)

Effect of Prophylaxis of Amiodarone and Magnesium to Prevent Atrial Fibrillation in Patients with Rheumatic Valve Disease Undergoing Mitral Valve Replacement Surgery
por: Sharma, Shruti, et al.
Publicado: (2020)

Virus Hepatitis Update
por: Hewitt, P E
Publicado: (2000)

Virus Hepatitis Update
por: Summerfield, John A
Publicado: (2000)

Colonoscopy-related colonic ischemia
por: Sadalla, Sinan, et al.
Publicado: (2021)

Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study
por: Kiltz, Uta, et al.
Publicado: (2021)

Update on Immunosuppression in Liver Transplantation
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

Reply to: “Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?”
por: Matthews, Philippa C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tkqa6lou6dj3sqvie6lobipid4